SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-007173
Filing Date
2024-01-24
Accepted
2024-01-24 21:05:37
Documents
2
Period of Report
2024-01-24

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 6750
2 EX-24 cgon-ex24.htm EX-24 19147
  Complete submission text file 0000950170-24-007173.txt   27386
Mailing Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618
Business Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618 (949) 419-6203
CG Oncology, Inc. (Issuer) CIK: 0001991792 (see all company filings)

IRS No.: 371611499 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O CG ONCOLOGY, INC. 400 SPECTRUM CENTER DRIVE, SUITE 2040 IRVINE CA 92618
Business Address
Kuan Arthur (Reporting) CIK: 0002007101 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41925 | Film No.: 24558391